Pre- and post-operative nomograms to predict recurrence-free probability in Korean men with clinically localized prostate cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Kang, Minyong ^a   Jeong, Chang Wook ^a   Choi, Woo Suk ^a   Park, Yong Hyun ^b   Cho, Sung Yong ^c   Lee, Sangchul ^b   Lee, Seung Bae ^c   Ku, Ja Hyeon ^a   Hong, Sung Kyu ^b   Byun, Seok Soo ^b   Jeong, Hyeon ^c   Kwak, Cheol ^a   Kim, Hyeon Hoe ^a   Lee, Eunsik ^a   Lee, Sang Eun ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ASIAN; CALIBRATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; GLEASON SCORE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KOREAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE EVALUATION; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY; SAMPLING; SEMINAL VESICLE DISEASE; TERTIARY HEALTH CARE; TUMOR INVASION; VALIDATION STUDY; CANCER GRADING; DISEASE FREE SURVIVAL; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SOUTH KOREA;

AGED; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NOMOGRAMS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA;

EID: 84903289150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100053     Document Type: Article

References (33)

1. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G (2008) The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 15: 3866-3871.
2. Yan Y, Carvalhal GF, Catalona WJ, Young JD (2000) Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 88: 1122-1130. (Pubitemid 30127674)
3. Fichtner J (2000) The management of prostate cancer in patients with a rising prostate-specific antigen level. BJU Int 86: 181-190;quiz ii-iii.
4. Sengupta S, Blute ML, Bagniewski SM, Myers RP, Bergstralh EJ, et al. (2006) Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. J Urol 175: 1684-1690; discussion 1690.
5. Naito S (2005) Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer. Jpn J Clin Oncol 35: 365-374.
6. Stephenson AJ, Kattan MW (2006) Nomograms for prostate cancer. BJU Int 98: 39-46. (Pubitemid 43885501)
7. Kattan MW, Stapleton AM, Wheeler TM, Scardino PT (1997) Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 79: 528-537. (Pubitemid 27051778)
8. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW (2008) An updated catalog of prostate cancer predictive tools. Cancer 113: 3075-3099.
9. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400-4407.
10. Iremashvili V, Lokeshwar SD (2012) Editorial comment to nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol 19: 853-854.
11. Jeong CW, Jeong SJ, Hong SK, Lee SB, Ku JH, et al. (2012) Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol 19: 846-852; author reply 853-844.
12. Jeong CW, Byun SS, Lee E, Lee SE, Chung BH, et al. (2013) Seoul National University Prostate Cancer Stage Calculator: Generalization and Head-to-Head Comparison with 2013 Partin Table by Multicenter Cohort. Korean J Urol Oncol 11: 133-140.
13. Song C, Kang T, Ro JY, Lee MS, Kim CS, et al. (2005) Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 20: 262-266. (Pubitemid 40627109)
14. Chung JS, Choi HY, Song HR, Byun SS, Seo S, et al. (2010) Preoperative nomograms for predicting extracapsular extension in Korean men with localized prostate cancer: a multi-institutional clinicopathologic study. J Korean Med Sci 25: 1443-1448.
15. Kim KH, Lim SK, Kim HY, Han WK, Choi YD, et al. (2013) Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era. BJU Int. DOI: 10.1111/bju.12280.
16. Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT (2009) Critical review of prostate cancer predictive tools. Future Oncol 5: 1555-1584.
17. Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology 26: 1364-1370.
18. Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, et al. (2008) External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 26: 1526-1531.
19. Chatterjee S (1998) Another look at the jackknife: further examples of generalized bootstrap. Statistics & Probability Letters 40: 307-319.
20. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90: 766-771. (Pubitemid 28259189)
21. Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17: 1499-1507. (Pubitemid 29220858)
22. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr., Dotan ZA, et al. (2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98: 715-717. (Pubitemid 43821789)
23. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, et al. (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61: 1079-1092.
24. Song C, Ro JY, Lee MS, Hong SJ, Chung BH, et al. (2006) Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 68: 820-824. (Pubitemid 44633367)
25. Byun SS, Lee S, Lee SE, Lee E, Seo SI, et al. (2012) Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations. Yonsei Med J 53: 543-549.
26. Li XG, Zhang DX, Cui XG, Xu DF, Hong Y, et al. (2012) Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy. Chin Med J (Engl) 125: 1529-1535.
27. Chung JS, Choi HY, Song HR, Byun SS, Seo SI, et al. (2011) Nomogram to predict insignificant prostate cancer at radical prostatectomy in Korean men: a multi-center study. Yonsei Med J 52: 74-80.
28. Cho YM, Jung SJ, Cho N, Kim MJ, Kattan MW, et al. (2013) Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer. World J Urol. DOI:10.1007/s00345-013-1111-6.
29. Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26: 565-574. (Pubitemid 44728772)
30. Kotb AF, Elabbady AA (2011) Prognostic factors for the development of biochemical recurrence after radical prostatectomy. Prostate Cancer 2011: 485189.
31. Swanson GP, Basler JW (2010) Prognostic factors for failure after prostatectomy. J Cancer 2: 1-19.
32. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr., et al. (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24: 3973-3978. (Pubitemid 46630746)
33. Freedland SJ, Moul JW (2007) Prostate specific antigen recurrence after definitive therapy. J Urol 177: 1985-1991. (Pubitemid 46726405)